AND (Gene)

Summary

AND is a gene with significant involvement in neurological disease research, particularly Alzheimer’s disease and related neurodegeneration pathways. It participates in key cellular processes including oxidative stress response and apoptosis, and shows expression in endothelial cells. The gene interacts with multiple targets and pathways implicated in Alzheimer’s disease pathogenesis, suggesting its potential role as a therapeutic target.

Biological Function

AND participates in several critical cellular pathways:

Pathway/Process	Evidence Strength
Oxidative stress response	0.90
Apoptosis pathway	0.80
Ubiquitin-proteasome pathway	0.70

Cellular Expression: AND is expressed in endothelial cells, indicating potential roles in vascular function and blood-brain barrier integrity.

Key Relationships

Incoming Relationships (regulated/interacted by others)

Interacting Entity	Relationship Type	Strength
AKT1S1	Regulates	0.60
RIPK1	Interacts	0.60
MAP1LC3A	Interacts	0.60
GRB2	Interacts	0.60
CFTR	Regulates	0.60
TP53	Interacts	0.60
APOPTOSIS	Interacts	0.60
CYTOKINES	Activates	0.60

Outgoing Relationships

Target	Relationship Type	Strength
PS1 (Presenilin-1)	Associated	0.70
APOE	Therapeutic target	0.60
REELIN	Therapeutic target	0.60

Disease Associations

Alzheimer’s Disease (Primary Association)

• Interaction Strength: 0.70
• Therapeutic Target: 0.65

AND demonstrates strong associations with Alzheimer’s disease through multiple mechanisms:

• Direct interaction with Alzheimer’s disease pathology
• Association with PS1 (Presenilin-1), a well-characterized Alzheimer’s disease gene
• Connection to APOE and REELIN, both implicated in AD pathogenesis

Neurodegeneration

• Association Strength: 0.70

AND is broadly associated with neurodegeneration processes, supported by its involvement in oxidative stress response, apoptosis pathways, and ubiquitin-proteasome function—all mechanisms commonly dysregulated in neurodegenerative diseases.

Carcinoma

• Interaction Strength: 0.65

AND also shows interactions with carcinoma, suggesting potential broader roles in cellular proliferation and cell death regulation.

Research Context

Hypotheses Mentioning AND

AND has been referenced in several mechanistic hypotheses related to neurodegeneration:

1. Closed-loop transcranial focused ultrasound with 40Hz gamma entrainment to restore hippocampal-cortical connectivity in early MCI (Score: 1.00)

   • Connected to PVALB modulation and hippocampal-cortical connectivity

2. Metabolic Reprogramming to Reverse Senescence (Score: 1.00)

   • Focuses on senescence reversal in neurodegeneration

3. TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegeneration (Score: 0.99)

   • Modulation of TREM2 within neurodegeneration context

4. SASP Modulation Rather Than Cell Elimination (Score: 0.98)

   • Involves modulation of NFKB1, IL1B, BDNF in neurodegeneration

5. TREM2-Dependent Microglial Senescence Transition (Score: 0.95)

   • Focuses on microglial senescence dynamics

SciDEX Analyses

No formal SciDEX analyses have been conducted specifically for AND.

References

Literature Citations: 10 papers reference this entity

• PMID: 39498803
• PMID: 39891319
• PMID: 40409316 — “Protective genetic variants against Alzheimer’s disease”
• PMID: 34980874
• PMID: 40531278

---

Note: This wiki page summarizes knowledge graph relationships and available literature. For detailed functional characterization, please refer to the cited primary literature.